资产 更改
Adidas EUR 20.45B 192M 2026-03
Adyen EUR 12.26B 1.68B 2025-12
Akzo Nobel EUR 15.49B 1.53B 2026-03
Alcon AG USD 31.62B 64M 2026-03
Amadeus IT EUR 11.43B 44.1M 2026-03
Amarin USD 645.76M 25.01M 2026-03
AstraZeneca USD 114.02B 59M 2026-03
BASF EUR 76.17B 267M 2025-12
Bayer EUR 107.94B 3.4B 2026-03
Beiersdorf EUR 12.76B 166M 2025-12
Covestro EUR 13.47B 245M 2025-12
Danone EUR 45.07B 1.32B 2025-12
Fresenius EUR 41.4B 1.07B 2025-12
Fresenius Medical Care EUR 31.47B 465.26M 2026-03
Genmab DKK 12.87B 5.85B 2025-12
Givaudan CHF 11.86B 587M 2025-12
GlaxoSmithKline GBP 62.87B 1.75B 2026-03
GRIFOLS EUR 20.08B 366M 2026-03
Henkel EUR 32.53B 258M 2025-12
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Infineon EUR 31.72B 978M 2026-03
Lakefront Biotherapeutics EUR 3.37B 34.09M 2026-03
Linde USD 86.82B 824M 2025-12
Lonza CHF 18.97B 164M 2025-12
Merck EUR 53.07B 1.54B 2026-03
Novartis USD 118.53B 7.58B 2026-03
Philips EUR 27.27B 322M 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12
Sanofi EUR 128.02B 1.22B 2026-03
UCB EUR 18.16B 971M 2025-12